Rome Therapeutics

Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
BioSpace
Sun, 09/17/23 - 09:45 pm
biotech
IPOs
Neumora Therapeutics
Rome Therapeutics
Generate Biomedicines
Rome, backed by Arch and GV, hires science leaders to hit targets in “junk DNA”
Fierce Biotech
Mon, 07/19/21 - 11:02 am
Rome Therapeutics
junk DNA
cancer
autoimmune